Substandard, falsified and unregistered medicines in Latin America, 2017-2018
Objective. To assess all the incidents of substandard, falsified and unregistered medicines in 2017 and 2018 in Latin America, determining the types of products affected, stages of the supply chain in which incidents were detected, quality deviations identified in tested samples, and regulatory meas...
Saved in:
Main Author: | Robin Rojas-Cortés (Author) |
---|---|
Format: | Book |
Published: |
Pan American Health Organization,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of substandard, falsified, unlicensed and unregistered medicine and its associated factors in Africa: a systematic review
by: Biset Asrade Mekonnen, et al.
Published: (2024) -
Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020) -
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019) -
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
by: Elizabeth Pisani, et al.
Published: (2021) -
Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
by: Faris El-Dahiyat, et al.
Published: (2021)